Business

Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers

CRYSTAL LAKE, Ill., October 16, 2025--Aptar Digital Health's HeroTracker® Sense has been granted by the U.S Food and Drug Administration 510(k) clearance as a Class II Medical Device.

articleAptargroup, Inc.October 16, 20253/company/aptargroup-inc/news/aptar-digital-health-announces-fda-120000418
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers

About this update from Aptargroup, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":795,"height":290,"url":"https://media.zenfs.com/en/business-wire.com/807d345c1db701886e3da24ed6b21c83"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ZqswGxFXmoQKS7HMaoGn3Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM1MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/807d345c1db701886e3da24ed6b21c83","width":795,"height":290},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/MFPVn3pkedDANlj4LWbhAw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE1OTA7aD01ODA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/807d345c1db701886e3da24ed6b21c83","width":795,"height":290}},"lazy":false},{"type":"text","content":"CRYSTAL LAKE, Ill., October 16, 2025--(BUSINESS WIRE)--Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S Food and Drug Administration (FDA) has granted 510(k) clearance for HeroTracker® Sense as a Class II medical device. This milestone recognizes HeroTracker® Sense - a Bluetooth-enabled sensor - as an innovative connected add-on for pressurized Metered Dose Inhalers (pMDIs), transforming traditional inhalers into smart, data-driven devices for patients and healthcare professionals.","length":566,"tagName":"p"},{"type":"text","content":"Designed for individuals aged 12 and above, HeroTracker® Sense is compatible with several commonly prescribed asthma and chronic obstructive pulmonary disease (COPD) medications, including Ventolin® HFA, Advair®, and certain albuterol and fluticasone/salmeterol inhalers. Integrated within Aptar Digital Health’s Respiratory Disease Management Platform, HeroTracker® Sense supports users in managing their respiratory health through comprehensive medication and symptom management. The platform delivers real-time usage tracking, personalized reminders and educational resources via an intuitive mobile application, encouraging behavior change and adherence to prescribed therapies. By enabling patients to monitor inhaler techniques and receive instant feedback, the platform aims to support improved respiratory health.","length":821,"tagName":"p"},{"type":"text","content":""By combining inhalation therapy with advanced digital health solutions, we aim to support patients in improving adherence a...

More updates from Aptargroup, Inc.

Digital Healthrespiratory healthAptarFood and Drug AdministrationMetered Dose Inhalersmedicationsconnected solutionsSenseinhalation therapymedical device